Journal
EUROPEAN JOURNAL OF INTERNAL MEDICINE
Volume 48, Issue -, Pages 18-24Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejim.2017.10.005
Keywords
Obesity; Metabolic disease; Gut microbiota
Categories
Funding
- European Metacardis project [HEALTH-F4_2012_305312]
- Heart and Artery Association (Fondacoeur)
- clinical research contracts (AP/HP Microbaria)
- National Research Agency (ANR)
Ask authors/readers for more resources
The composition and function of gut microbiota play a role in obesity and metabolic disease, yet the mechanisms have not been fully described. As new discoveries and advances in the field have occurred, the relevance of gut microbiota in clinical care has become more substantial. There is promising potential for manipulation of the gut microbiota as treatment of obesity and associated health complications, both as a standalone therapy and as part of interventions such as weight loss. In this review we have compiled knowledge and concepts that are important in the consideration of gut microbiota for clinical care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available